These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27293250)

  • 21. Corneal densitometry in patients with arcus senilis and its correlation with serum lipid levels.
    Yilmaz YC; Ipek SC; Ozer MD; Celebi T
    Indian J Ophthalmol; 2022 May; 70(5):1556-1563. PubMed ID: 35502026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [COMBINED THREE OPERATIONS FOR ONE STAGE DEFECTS REPAIR AFTER RESECTION OF LARGE XANTHELASMA PALPEBRARUM WITH EPICANTHUS].
    Zeng L; Chen J; Cen Y; Lei L; Qin X; Wang Y; Zeng C
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2016 Sep; 30(9):1130-1133. PubMed ID: 29786369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Xanthelasma palpebrarum associated with increased cardio-ankle vascular index in asymptomatic subjects.
    Akyüz AR; Turan T; Erkuş ME; Gürbak İ; Kul S; Korkmaz L; Ağaç MT; Çelik Ş
    Wien Klin Wochenschr; 2016 Dec; 128(Suppl 8):610-613. PubMed ID: 26975453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intralesional injection of bleomycin in the treatment of xanthelasma palpebrarum: A clinical study.
    Lin X; Hu H; Qian Y; Jie X; Nie B; Zhao YZ; Wang H; Jiang H
    J Cosmet Dermatol; 2020 Aug; 19(8):2125-2130. PubMed ID: 31930760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Xanthelasma Palpebrarum: More than Meets the Eye.
    Khode S; Tan SHT; Tan EA; Uppal S
    Indian J Otolaryngol Head Neck Surg; 2019 Oct; 71(Suppl 1):439-446. PubMed ID: 31742000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pathogenesis and clinical significance of xanthelasma palpebrarum.
    Bergman R
    J Am Acad Dermatol; 1994 Feb; 30(2 Pt 1):236-42. PubMed ID: 8288783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case of intramuscular xanthelasma palpebrarum found during blepharoplasty.
    Chung YH; Kang SY; Choi WS
    Arch Craniofac Surg; 2018 Dec; 19(4):296-299. PubMed ID: 30613094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes of surgical management of xanthelasma palpebrarum.
    Lee HY; Jin US; Minn KW; Park YO
    Arch Plast Surg; 2013 Jul; 40(4):380-6. PubMed ID: 23898435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Corneal arcus associated with dyslipidemia.
    Lertchavanakul A; Laksanaphuk P; Tomtitchong T
    J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S231-5. PubMed ID: 12188416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Xanthelasma palpebrarum and dyslipoproteinaemia: two retrospective studies (author's transl)].
    Rouffy J; Chanu B; Bakir R; Goy-Loeper J; Bouthillier D; Goussault Y; Dreux C
    Ann Dermatol Venereol; 1982; 109(3):231-5. PubMed ID: 7114736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship Between Xanthelasma Palpebrarum and Hyperlipidemia.
    Wang KY; Hsu KC; Liu WC; Yang KC; Chen LW
    Ann Plast Surg; 2018 Feb; 80(2S Suppl 1):S84-S86. PubMed ID: 29424765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of Xanthelasma Palpebrarum using Pulsed Dye Laser: Original Report on 14 Cases.
    Thajudheen CP; Jyothy K; Arul P
    J Cutan Aesthet Surg; 2019; 12(3):193-195. PubMed ID: 31619894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and Lipid Profile Studies in Xanthelasma Palpebrarum.
    Reddy BS; Singh G; Pandey SS; Tiwari D
    Indian J Dermatol Venereol Leprol; 1983; 49(3):127-131. PubMed ID: 28176722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Clinical and Dermatoscopic Perspective of the Efficacy and Safety of Erbium: YAG Laser Ablation Versus 50% Trichloroacetic Acid for the Management of Xanthelasma Palpebrarum.
    Arora A; Mohta A; Mehta RD; Ghiya BC; Soni P; Jangir VK; Yadav MK; Khokhar R; Mangava V
    J Cutan Aesthet Surg; 2024; 17(1):1-6. PubMed ID: 38736854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Corneal arcus as coronary artery disease risk factor.
    Fernández A; Sorokin A; Thompson PD
    Atherosclerosis; 2007 Aug; 193(2):235-40. PubMed ID: 17049531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative Study to Evaluate the Efficacy of Radiofrequency Ablation versus Trichloroacetic Acid in the Treatment of Xanthelasma Palpebrarum.
    Reddy PK; Kunneth ST; Lakshminarayana SP; Yallappa SM; Chandrashekara R; Nanjundaswamy SK
    J Cutan Aesthet Surg; 2016; 9(4):236-240. PubMed ID: 28163454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Xanthelasma palpebrarum and its relation to atherosclerotic risk factors and lipoprotein (a).
    Ozdöl S; Sahin S; Tokgözoğlu L
    Int J Dermatol; 2008 Aug; 47(8):785-9. PubMed ID: 18717856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2017 Taiwan lipid guidelines for high risk patients.
    Li YH; Ueng KC; Jeng JS; Charng MJ; Lin TH; Chien KL; Wang CY; Chao TH; Liu PY; Su CH; Chien SC; Liou CW; Tang SC; Lee CC; Yu TY; Chen JW; Wu CC; Yeh HI;
    J Formos Med Assoc; 2017 Apr; 116(4):217-248. PubMed ID: 28242176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical spectrum of xanthomatous lesions of the eyelids.
    Baykal C; Polat Ekinci A; Yazganoglu KD; Buyukbabani N
    Int J Dermatol; 2017 Oct; 56(10):981-992. PubMed ID: 28500693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic review of laser therapy in xanthelasma palpebrarum.
    Nguyen AH; Vaudreuil AM; Huerter CJ
    Int J Dermatol; 2017 Mar; 56(3):e47-e55. PubMed ID: 28181222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.